We suggest that the evidence shows that although antipsychotics are effective in alleviating some, although often not all, of the symptoms of schizophrenia, there is no evidence that they treat the underlying disorder. The editorial was highlighting the fact that the clinical syndrome of patients with psychosis and N-methyl-d-aspartate receptor antibodies is the same as those with schizophrenia, such that most patients with this new disorder have previously received diagnoses of schizophrenia. However, as O’Laughlin et al state, having an identifiable cause invalidates the diagnosis of schizophrenia according to ICD. We agree that a syndrome of psychoses is a better diagnostic construct. This situation is not unique to psychiatry. In epilepsies, despite the rapid advance in discovery of aetiological factors, the diagnosis remains based on the clinical presentation of the seizures.